Introduction to the innovative targeted drug capmatinib

Capmatinib, as a breakthrough targeted drug, has attracted widespread attention in the field of lung cancer treatment in recent years. It is produced by Novartis Pharmaceuticals. After rigorous clinical trials and approval processes, it was approved by the US FDA for marketing in 2020, providing a new treatment option for patients with specific types of lung cancer. Capmatinib is mainly used to treat non-small cell lung cancer with mesenchymal epithelial transition (MET) exon 14 skip mutation. Lung cancer patients with this type of mutation are often insensitive to traditional chemotherapy, and the emergence of capmatinib brings hope to these patients.

In terms of usage and dosage, the recommended dose of capmatinib is 400 mg orally twice a day. It can be taken with or without food, but the tablet should be swallowed whole and should not be broken, crushed or chewed. When patients use capmatinib, they should strictly follow the doctor's instructions and should not change the dosage or medication time at will.

There are a few things patients need to pay attention to when using capmatinib. First, for patients with hepatic and renal insufficiency, the dosage may need to be adjusted. Secondly, capmatinib may interact with other drugs, so you should inform your doctor in detail about other drugs you are taking before using it. In addition, pregnant and breastfeeding women should seek medical advice before use.

In terms of purchase and price, capmatinib is currently sold abroad. In terms of price, due to different pricing strategies and market conditions in different countries and regions, prices will vary. For example, the Hong Kong version is approximately 35,000 per box (200mg*60 tablets), and the European version is approximately 57,000 per box (200mg*120 tablets). In addition, generic drugs of capmatinib are also sold in Laos, and the price is roughly around 3,000 to 4,000. The specific price needs to be determined according to the version selected by the patient and the time of purchase. In order to ensure the authenticity of the medicine and the reasonableness of the price, it is recommended that patients purchase it through formal channels and consult in detail about the price information of each sales channel.

Overall, capmatinib, as an innovative targeted drug, provides a new treatment option for patients with specific types of lung cancer. When using it, patients should strictly follow the doctor's instructions and pay attention to relevant medication matters. At the same time, in order to ensure the authenticity of drugs and the reasonableness of prices, patients should purchase them through formal channels.